According to Adverum Biotechnologies 's latest financial reports the company's current EPS (TTM) is -โน113.97. In 2022 the company made an earnings per share (EPS) of -โน132.83 a decrease over its 2021 EPS that were of -โน126.83.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน109.15 | -17.82% |
2022 | -โน132.83 | 4.73% |
2021 | -โน126.83 | 8.03% |
2020 | -โน117.40 | 35.64% |
2019 | -โน86.55 | -14.41% |
2018 | -โน101.12 | -8.53% |
2017 | -โน110.55 | -59.94% |
2016 | -โน275.94 | 73.58% |
2015 | -โน158.97 | 29.06% |
2014 | -โน123.18 | 465.99% |
2013 | -โน21.76 |